Literature DB >> 32406370

Narcolepsy with resolution of cataplexy and persisting orexin deficiency.

Danielle Wasserman1,2, Claudio L A Bassetti3,4, Ivana Rosenzweig1,2.   

Abstract

None: Narcolepsy type 1 is a debilitating chronic neurological disorder, whose main symptoms of excessive daytime sleepiness and cataplexy may partially improve with time, but typically do not fully resolve. The irreversible loss of orexin neurons is considered to be the pivotal mechanistic link underlying the development of cataplectic attacks in narcolepsy type 1. Here we describe a case of untreated narcolepsy type 1with low cerebrospinal orexin levels (< 50 pg/mL), where cataplexy fully resolved in the first 5-6 years after disease onset, whereas excessive daytime sleepiness persisted.
© 2020 American Academy of Sleep Medicine.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32406370      PMCID: PMC7446074          DOI: 10.5664/jcsm.8572

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  15 in total

1.  Dysregulation of regional endogenous opioid function in borderline personality disorder.

Authors:  Alan R Prossin; Tiffany M Love; Robert A Koeppe; Jon-Kar Zubieta; Kenneth R Silk
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

Review 2.  Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.

Authors:  Claudio L A Bassetti; Antoine Adamantidis; Denis Burdakov; Fang Han; Steffen Gay; Ulf Kallweit; Ramin Khatami; Frits Koning; Brigitte R Kornum; Gert Jan Lammers; Roland S Liblau; Pierre H Luppi; Geert Mayer; Thomas Pollmächer; Takeshi Sakurai; Federica Sallusto; Thomas E Scammell; Mehdi Tafti; Yves Dauvilliers
Journal:  Nat Rev Neurol       Date:  2019-07-19       Impact factor: 42.937

3.  Social feedback activates the endogenous opioid system.

Authors:  D T Hsu; B J Sanford; K K Meyers; T M Love; K E Hazlett; H Wang; L Ni; S J Walker; B J Mickey; S T Korycinski; R A Koeppe; J K Crocker; S A Langenecker; J-K Zubieta
Journal:  Mol Psychiatry       Date:  2013-11       Impact factor: 15.992

4.  Life effects of narcolepsy: relationships to geographic origin (North American, Asian or European) and to other patient and illness variables.

Authors:  R Broughton; Q Ghanem; Y Hishikawa; Y Sugita; S Nevsimalova; B Roth
Journal:  Can J Neurol Sci       Date:  1983-05       Impact factor: 2.104

5.  Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation?

Authors:  Panagis Drakatos; Guy Leschziner
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

6.  Endogenous opioids regulate moment-to-moment neuronal communication and excitability.

Authors:  Bryony L Winters; Gabrielle C Gregoriou; Sarah A Kissiwaa; Oliver A Wells; Danashi I Medagoda; Sam M Hermes; Neil T Burford; Andrew Alt; Sue A Aicher; Elena E Bagley
Journal:  Nat Commun       Date:  2017-03-22       Impact factor: 14.919

7.  Preclinical and Clinical Evidence for a Distinct Regulation of Mu Opioid and Type 1 Cannabinoid Receptor Genes Expression in Obesity.

Authors:  Mariangela Pucci; Maria Vittoria Micioni Di Bonaventura; Valeria Vezzoli; Elizabeta Zaplatic; Marcella Massimini; Stefania Mai; Alessandro Sartorio; Massimo Scacchi; Luca Persani; Mauro Maccarrone; Carlo Cifani; Claudio D'Addario
Journal:  Front Genet       Date:  2019-06-14       Impact factor: 4.599

Review 8.  Narcolepsy in Children and Adults: A Guide to Improved Recognition, Diagnosis and Management.

Authors:  Anne Marie Morse
Journal:  Med Sci (Basel)       Date:  2019-11-27

9.  Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy.

Authors:  Thomas C Thannickal; Joshi John; Ling Shan; Dick F Swaab; Ming-Fung Wu; Lalini Ramanathan; Ronald McGregor; Keng-Tee Chew; Marcia Cornford; Akihiro Yamanaka; Ayumu Inutsuka; Rolf Fronczek; Gert Jan Lammers; Paul F Worley; Jerome M Siegel
Journal:  Sci Transl Med       Date:  2018-06-27       Impact factor: 17.956

10.  Clinical and polysomnographic course of childhood narcolepsy with cataplexy.

Authors:  Fabio Pizza; Christian Franceschini; Hanna Peltola; Stefano Vandi; Elena Finotti; Francesca Ingravallo; Lino Nobili; Oliviero Bruni; Ling Lin; Mark J Edwards; Markku Partinen; Yves Dauvilliers; Emmanuel Mignot; Kailash P Bhatia; Giuseppe Plazzi
Journal:  Brain       Date:  2013-10-18       Impact factor: 13.501

View more
  1 in total

Review 1.  Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know.

Authors:  Lois E Krahn; Phyllis C Zee; Michael J Thorpy
Journal:  Adv Ther       Date:  2021-12-11       Impact factor: 3.845

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.